In a bid to boost its robotic offerings for its customers, global medical technology company Smith & Nephew has successfully completed the acquisition of Atracsys Sàrl – the Switzerland-headquartered business which creates and develops optical tracking technology commonly used in computer-supported operations.
Although the commercial terms of the deal have not been disclosed to the public, the acquisition, which was initiated in June this year, supports Smith & Nephew’s long-term goal of investing in a range of digital surgery technologies to enhance its robotics portfolio. The end result is to empower surgeons and better clinical results.
Due to release commercially in 2020, Atracsys Sàrl’s fusionTrack 500 technology features optical tracking cameras which will feature in a number of Atracsys’ robotics services. As a result of its ability to improve measurement speed and latency performance, operation times are significantly reduced, and operational accuracy is increased. In particular, and in comparison to existing technology, the fusionTrack 500 will boost the precision of surgical procedures, such as bone cuts.
Atracsys Sàrl presently provides services to surgeons operating in the orthopaedic, neurological, spinal and dental industries, with potential for its technology to expand into more medical departments.
This particular acquisition is part of Smith & Nephew’s goal to continue growing through more mergers and acquisitions in the future. Just last month, it finalised the takeover of Brainlab’s orthopaedic joint reconstruction business.